Figure 1. T1-weighted images, 1 min post IV Gadolinium. A patient with metastatic liver disease treated as part of the Oxford trial.
Figure 2. A patient with a renal tumour treated as part of the Oxford trial. Axial T1W MRI (1 min post-gadolinium contrast) subtraction films. (a) Renal tumour showing contrast enhancement before HIFU. Ablated region with absent contrast uptake (b) 12 days, (c) 6 months and (d) 1 year after HIFU.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.